Skip to main content
OpenTrials

Clinical trial condition

Stage IIIC Breast Cancer AJCC v7

Explore clinical trials studying Stage IIIC Breast Cancer AJCC v7. Study availability and eligibility vary by location and protocol.

32 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stage IIIC Breast Cancer AJCC v7 trial results

Completed

Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer

NCT01275677

Conditions
Breast Diseases, Breast Neoplasms, HER2/Neu Positive, +12 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 1283 locations
View Trial Details
Completed

Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer

NCT01349959

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +10 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

NCT01638533

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details
Completed

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

NCT01142401

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Carcinoma, +7 more
Locations
  • University of Connecticut Farmington, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • Cleveland Clinic-Weston Weston, Florida, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 21 locations
View Trial Details
Completed

Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

NCT02152943

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
  • MD Anderson in Sugar Land Sugar Land, Texas, United States
View Trial Details
Completed

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer

NCT00684983

Conditions
Breast Diseases, Breast Neoplasms, HER2 Positive Breast Carcinoma, +9 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Mills-Peninsula Medical Center Burlingame, California, United States
View all 390 locations
View Trial Details

Related conditions